ORCL#330
Thesis
Q4 earnings beat across all metrics: revenue, EPS, and RPOs ($638B vs $590B est, +363% YoY); strong FY28 guidance
Original post text
$ORCL Q4 EARNINGS: Revenue $19.2B vs Est. $19.1B, EPS $2.11 vs Est. $1.97, RPOs $638B vs Est. $590B (+363% YoY). FY28 Guidance: Revenue $90B vs Est. $89B.
🐂 Bull Case
- Revenue growth of 20.6% accelerating; if maintained, supports premium valuation
🐻 Bear Case
- Trading 44.8% below 52-week high; weak relative strength
🚫 Invalidation
Price closes below SMA200 (205.1) on above-average volume
Break Conditions
- Price closes below SMA200 (205.1) on above-average volume
- Core thesis invalidated if Q4 earnings beat across all metrics: revenue, EPS, and RPOs proves incorrect
Metadata
T0 Price: $179.82
Created: 2026-06-11 18:34:42
Scored: 2026-06-11T18:35:39.876961+00:00
Updated: 2026-06-11T18:35:39.876980+00:00